Pretreatment C-reactive Protein to Albumin Ratio Predicts Clinical Outcomes in Patients with Peripheral T-cell LymphomaJongheon Jung(National Cancer Center), Hyeon‐Seok Eom(National Cancer Center)Research SquareJanuary 13, 202210.21203/rs.3.rs-1240904/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersIdentification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling|BMC Cancer|2010|47High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma|Scientific Reports|2021|14